GlassScriptPhysician profile
Khan Adnan
NPI 1376528406
$753.32
in general payments reported to CMS, 2019-2025
16 companies · $401 in 2025
The $401 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.36 · 2020: $30.23 · 2021: $19.36 · 2022: $14.34 · 2023: $146 · 2024: $113 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $158.16 | 2023-2025 | Azstarys |
| Cipher Pharmaceuticals US LLC | $138.25 | 2025 | Spinosad, Natroba |
| Pfizer INC. | $89.40 | 2019-2024 | |
| Sanofi Pasteur INC. | $68.07 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $57.50 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $35.73 | 2023-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Phadia US INC. | $33.07 | 2019-2025 | Immunocap |
| Supernus Pharmaceuticals, INC. | $28.02 | 2023-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $22.02 | 2024 | |
| Seqirus USA INC | $21.64 | 2024 | Flucelvax |
| Verrica Pharmaceuticals INC. | $19.54 | 2025 | Ycanth |
| Cranial Technologies, INC | $19.02 | 2023 | Doc Band |
| Collegium Pharmaceutical, INC. | $18.33 | 2025 | Jornay Pm |
| Kaleo, INC. | $15.54 | 2020 | |
| Glaxosmithkline, LLC. | $14.69 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khan Adnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.